Development and validation of a MEPS-UHPLC-PDA method for determination of ulifloxacin in human plasma and urine of patients with peripheral arterial disease.
暂无分享,去创建一个
[1] Paola Palumbo,et al. Bioanalytical method development for quantification of ulifloxacin, fenbufen and felbinac in rat plasma by solid-phase extraction (SPE) and HPLC with PDA detection. , 2016, Journal of pharmaceutical and biomedical analysis.
[2] R. Cifelli,et al. Stability study of Prulifloxacin and Ulifloxacin in human plasma by HPLC–DAD , 2016, Journal of enzyme inhibition and medicinal chemistry.
[3] M. Moein,et al. Microextraction by packed sorbent (MEPS) , 2015 .
[4] R. Cifelli,et al. Microextraction by packed sorbent and high performance liquid chromatography determination of seven non-steroidal anti-inflammatory drugs in human plasma and urine. , 2014, Journal of chromatography. A.
[5] J. Câmara,et al. Microextraction by packed sorbent: an emerging, selective and high-throughput extraction technique in bioanalysis. , 2014, Biomedical chromatography : BMC.
[6] L. Andersson,et al. Molecularly imprinted polymer in microextraction by packed sorbent for the simultaneous determination of local anesthetics: lidocaine, ropivacaine, mepivacaine and bupivacaine in plasma and urine samples. , 2013, Biomedical chromatography : BMC.
[7] Baldev Singh,et al. Liquid chromatographic determination of quinolones in water and human urine samples after microextraction by packed sorbent. , 2012, Journal of AOAC International.
[8] Hongyuan Yan,et al. Simultaneous analysis of fluoroquinolones and xanthine derivatives in serum by molecularly imprinted matrix solid-phase dispersion coupled with liquid chromatography. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] T. Pal,et al. Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study. , 2011, Biomedical chromatography : BMC.
[10] M. Falagas,et al. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections. , 2011, International journal of antimicrobial agents.
[11] Hanqi Zhang,et al. Determination of fluoroquinolones in blood by matrix solid-phase dispersion extraction and CE. , 2011, Journal of separation science.
[12] K. Maitland,et al. Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: Application to a population pharmacokinetics study in children with severe malnutrition , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] S. Watabe,et al. Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] M. Raggi,et al. Liquid chromatographic analysis of oxcarbazepine and its metabolites in plasma and saliva after a novel microextraction by packed sorbent procedure. , 2010, Analytica chimica acta.
[15] Hiroyuki Kataoka,et al. Recent developments and applications of microextraction techniques in drug analysis , 2010, Analytical and bioanalytical chemistry.
[16] M. Valcárcel,et al. Fully automatic sample treatment by integration of microextraction by packed sorbents into commercial capillary electrophoresis-mass spectrometry equipment: application to the determination of fluoroquinolones in urine. , 2009, Analytical chemistry.
[17] C. Tascini,et al. Prulifloxacin: clinical studies of a broad-spectrum quinolone agent. , 2009, Future microbiology.
[18] G. Fan,et al. Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[19] Weidong Qin,et al. Capillary electrophoresis-chemiluminescence determination of norfloxacin and prulifloxacin. , 2008, Analytica chimica acta.
[20] R. Pellegrino,et al. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography. , 2008, Journal of pharmaceutical and biomedical analysis.
[21] Lin-pei Jin,et al. Determination of ulifloxacin by terbium-sensitized fluorescence with second-order scattering and its applications. , 2007, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[22] G. Fan,et al. Determination of the Active Metabolite of Prulifloxacin in Human Plasma by HPLC with Fluorescence Detection , 2007 .
[23] Lixia Guo,et al. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] G. Prats,et al. Prulifloxacin: a new antibacterial fluoroquinolone , 2006, Expert review of anti-infective therapy.
[25] M. T. Rosignoli,et al. Pharmacokinetics and Tolerability of Prulifloxacin after Single Oral Administration , 2003, Arzneimittelforschung.
[26] G. Carlucci,et al. Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography. , 1998, Journal of chromatography. A.
[27] S. Watanabe,et al. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[28] G. Palumbo,et al. Analytical procedure for the determination of rufloxacin, a new pyridobenzothiazine, in human serum and urine by high-performance liquid chromatography. , 1991, Journal of Chromatography A.